SightfileU.S. market data from official filings

Companies › ALDX

ALDEYRA THERAPEUTICS INC (ALDX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001341235 · EDGAR filings · Updated 2026-07-27

ALDEYRA THERAPEUTICS INC (ALDX) has reported institutional ownership of 62.0%, with 124 institutional managers holding positions valued at $63.3M per the latest 13F reporting period.

Institutional ownership
62.0%
Institutional managers
124
Reported 13F value
$63.3M
Insider activity
5 trans.
−$4.82M net selling

Filings this week (1)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ALDEYRA THERAPEUTICS INC has 124 institutional holders and institutional ownership of 62.0%.

Insider activity

Insiders reported 5 transactions (3 buys, 2 sells) across 4 reporting insiders, with a net reported value of −$4.82M.

Related companies

LIFEMD (LFMD) · HUTCHMED CHINA LTD (HCM) · Achieve Life Sciences Inc (ACHV) · Pliant Therapeutics Inc (PLRX) · AVITA MEDICAL INC (RCEL) · NEURONETICS INC (STIM)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.